Skip to content

Scailyte & CHU Rennes announce Covid-19 partnership

Scailyte CHU Rennes announce Covid-19 partnership. Scailyte AG, a Swiss startup in the emerging and rapidly growing field of single-cell technologies, raised CHF 3.1 million in a pre-Series A round led by Swisscom Ventures.

Scailyte AG was founded in Luzern, Switzerland in July 2017. Scailyte is an ETH Zurich spin-off and is supported by Innosuisse (Swiss Innovation Agency). The company has gained recognition by winning several national and international start-up competitions, and is the beneficiary of significant research grants. Scailyte has a multi-disciplinary team with expertise in Cell biology, Genetics, Artificial Intelligence, Software development, Finance, Marketing and Sales.

The ScaiVision™ biomarker discovery platform delivers best-in-class performance for supervised
pattern recognition analysis of single-cell data. The performance and clinically-relevant application of the core deep learning algorithm of ScaiVision have been validated in several scientific papers and
have resulted in patent-pending diagnostic applications. For more information visit www.scailyte.com

Scailyte™ and ScaiVision™ are registered trademarks proprietary to Scailyte AG.

Recent News

Machine learning meets multi-omics for precision medicine

Bringing industry and academia together to discuss the potential impact of single-cell analytics pow

Read more

Recent News

Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies

Register for Scailyte's webinar on "Understanding Resistant to CAR-T Immunotherapy to Develop Better

Read more

Recent News

VACANCY: Technical Lead / Product Owner for a clinical diagnostic software

Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

Recent News

VACANCY: Data Scientist in Biomarker Discovery

Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

Recent News

True precision medicine through single-cell science - Nature

ScaiVision identifies disease signatures predicting drug efficacy & drug mode of action. Precision m

Read more

Recent News

Scailyte AG Announces a partnership with Sirona DX

Scailyte AG announces a strategic partnership with Sirona DX for AI-driven end-point specific single

Read more

Recent News

WEBINAR: Supervised learning of disease-associated cell states and dynamics

Watch Scailyte's webinar on "Supervised learning of disease-associated cell states and dynamics" wit

Read more

Recent News

PODCAST: Discovering diseases with artificial intelligence

PODCAST: Discovering diseases with artificial intelligence. Listen to this episode of Binary Dreams

Read more

Recent News

01 /04

Machine learning meets multi-omics for precision medicine

Bringing industry and academia together to discuss the potential impact of single-cell analytics pow

Read more

Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies

Register for Scailyte's webinar on "Understanding Resistant to CAR-T Immunotherapy to Develop Better

Read more

Recent News

02 /04

VACANCY: Technical Lead / Product Owner for a clinical diagnostic software

Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

VACANCY: Data Scientist in Biomarker Discovery

Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

Recent News

03 /04

True precision medicine through single-cell science - Nature

ScaiVision identifies disease signatures predicting drug efficacy & drug mode of action. Precision m

Read more

Scailyte AG Announces a partnership with Sirona DX

Scailyte AG announces a strategic partnership with Sirona DX for AI-driven end-point specific single

Read more

Recent News

04 /04

WEBINAR: Supervised learning of disease-associated cell states and dynamics

Watch Scailyte's webinar on "Supervised learning of disease-associated cell states and dynamics" wit

Read more

PODCAST: Discovering diseases with artificial intelligence

PODCAST: Discovering diseases with artificial intelligence. Listen to this episode of Binary Dreams

Read more

Recent News